Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Megapolitan Developments Tbk. (EMDE) vs Indofarma Tbk. (INAF)

Megapolitan Developments Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Megapolitan Developments Tbk. dan Indofarma Tbk.: Megapolitan Developments Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 264,65 M, volume 24 jam 4,45 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

EMDEINAF
Kapitalisasi Pasar
264,65 M390,51 M
Volume
4,45 jt
Lot
44,48 rb
Perputaran
344,65 jt
Harga Rata-rata
77,48
Nilai Transaksi
344,65 jt
Harga Ekuilibrium Indikatif
78
Volume Ekuilibrium Indikatif
853

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EMDE
Lihat detail
INAF
Lihat detail

Tentang Megapolitan Developments Tbk.

PT Megapolitan Developments (formerly Megapolitan Developments Corporation) (the Company) was established based on Notary Deed No. 24 dated September 10, 1976 by Soeleman Ardjasasmita, S.H., Notary in Jakarta.

Selengkapnya di halaman EMDE

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF